| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |